Press Release: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA
NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA). The class action, filed in the United States District Court for the Northern District of Illinois, and docketed under 24 -cv- 00977, is on behalf of…
Press Release: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA - Newscast
Fri, 26 Jul 2024 16:25:00 GMT Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR). Such investors are ...
Wed, 24 Jul 2024 13:07:00 GMT [Click here for information about joining the class action] On June 27, 2024, Elanco issued a press release "announc[ing] updates to ... to close at $14.28 per share on June 27, 2024. Pomerantz LLP, ...
Tue, 23 Jul 2024 15:45:00 GMT NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Agenus Inc. ("Agenus" or the "Company") (NASDAQ:AGEN). Such investors are advised to contact ...
Tue, 23 Jul 2024 12:59:00 GMT You have until September 9, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired MongoDB securities during the Class ...
Thu, 18 Jul 2024 18:39:00 GMT NEW YORK, July 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims ... On July 18, 2024, Agenus issued a press release "announc[ing] the results of its end-of-Phase 2 (EOP2) meeting ...
